检索结果 - Neha Luthar

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Nuclear EGFR as a molecular target in cancer

    Nuclear EGFR as a molecular target in cancer 由 Toni M. Brand, Mari Iida, Neha Luthar, Megan M. Starr, Evan J Huppert, Deric L. Wheeler

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab

    Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab 由 Mari Iida, Toni M. Brand, Megan M. Starr, Chunrong Li, Evan J Huppert, Neha Luthar, Mikkel W. Pedersen, Ivan D. Horak, Michael Kragh, Deric L. Wheeler

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

    Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy 由 Mari Iida, Toni M. Brand, Megan M. Starr, Evan J Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer

    Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer 由 Toni M. Brand, Mari Iida, Emily Dunn, Neha Luthar, Kellie T. Kostopoulos, Kelsey L. Corrigan, Matthew J. Wleklinski, David T. Yang, Kari B. Wisinski, Ravi Salgia, Deric L. Wheeler

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    AXL Mediates Resistance to Cetuximab Therapy

    AXL Mediates Resistance to Cetuximab Therapy 由 Toni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman, Neha Luthar, Mahmoud Toulany, Parkash S. Gill, Ravi Salgia, Randall J. Kimple, Deric L. Wheeler

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: